Suloctidil was a sulfur-containing
aminoalcohol that was brought to market in the early 1970s as a
vasodilator by Continental Pharma, a Belgian company.[1]: 118–121 [2][3]
Continental was bought by
Monsanto in 1984, primarily on the promise of sales of suloctidil, which was approved in Europe at the time, but not in the US.[4] However, in 1985 Monsanto halted development and withdrew the drug worldwide following reports of
liver toxicity.[5]: 251